Scotoma Reduction in AMD Patients Treated With Ranibizumab

A Phase I/II Study to Evaluate Scotoma Reduction in And Limited Visual Acuity in aGe Related Macular Degeneration Patients Treated With Intravitreal Lucentis

This is a trial aimed at patients with advanced wet macular degeneration and macular scarring treated wiht intravitreal injections of Lucentis.

Patients with severe wet macular degeneration and scarring in the center of the retina may benefit from treatment if the size of the blind spot is reduced wiht injections of Lucentis.

Inclusion Criteria:

• BCVA < 20/320
• Disciform macular degeneration wiht exudation

Exclusion Criteria:

• Non-amd CNV